Mounjar (tirzepatide) is a dual-targeted, injectable therapy indicated for the management of type 2 diabetes (T2D) in adults as an adjunct to diet and exercise.
Mounjar (tirzepatide) is a dual-targeted, injectable therapy indicated for the management of type 2 diabetes (T2D) in adults as an adjunct to diet and exercise.